148 related articles for article (PubMed ID: 23573144)
1. Antidiabetic effect and mode of action of cytopiloyne.
Chang CL; Liu HY; Kuo TF; Hsu YJ; Shen MY; Pan CY; Yang WC
Evid Based Complement Alternat Med; 2013; 2013():685642. PubMed ID: 23573144
[TBL] [Abstract][Full Text] [Related]
2. Cytopiloyne, a polyacetylenic glucoside, prevents type 1 diabetes in nonobese diabetic mice.
Chang CL; Chang SL; Lee YM; Chiang YM; Chuang DY; Kuo HK; Yang WC
J Immunol; 2007 Jun; 178(11):6984-93. PubMed ID: 17513748
[TBL] [Abstract][Full Text] [Related]
3. Cytopiloyne, a novel polyacetylenic glucoside from Bidens pilosa, functions as a T helper cell modulator.
Chiang YM; Chang CL; Chang SL; Yang WC; Shyur LF
J Ethnopharmacol; 2007 Apr; 110(3):532-8. PubMed ID: 17101254
[TBL] [Abstract][Full Text] [Related]
4. Insulinotropic action of 2, 4-dinitroanilino-benzoic acid through the attenuation of pancreatic beta-cell lesions in diabetic rats.
Jahan H; Choudhary MI; Manzoor M; Khan KM; Perveen S; Atta-Ur-Rahman
Chem Biol Interact; 2017 Aug; 273():237-244. PubMed ID: 28625491
[TBL] [Abstract][Full Text] [Related]
5. Anti-diabetic properties of three common Bidens pilosa variants in Taiwan.
Chien SC; Young PH; Hsu YJ; Chen CH; Tien YJ; Shiu SY; Li TH; Yang CW; Marimuthu P; Tsai LF; Yang WC
Phytochemistry; 2009 Jul; 70(10):1246-54. PubMed ID: 19683775
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic activities of entagenic acid in type 2 diabetic db/db mice and L6 myotubes via AMPK/GLUT4 pathway.
Xiong H; Zhang S; Zhao Z; Zhao P; Chen L; Mei Z
J Ethnopharmacol; 2018 Jan; 211():366-374. PubMed ID: 28993280
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice.
Thorkildsen C; Neve S; Larsen BD; Meier E; Petersen JS
J Pharmacol Exp Ther; 2003 Nov; 307(2):490-6. PubMed ID: 12975499
[TBL] [Abstract][Full Text] [Related]
9. Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice.
Han GC; Ko SK; Sung JH; Chung SH
J Agric Food Chem; 2007 Dec; 55(26):10641-8. PubMed ID: 18034458
[TBL] [Abstract][Full Text] [Related]
10. Circulating LncRNAs Analysis in Patients with Type 2 Diabetes Reveals Novel Genes Influencing Glucose Metabolism and Islet β-Cell Function.
Ruan Y; Lin N; Ma Q; Chen R; Zhang Z; Wen W; Chen H; Sun J
Cell Physiol Biochem; 2018; 46(1):335-350. PubMed ID: 29590649
[TBL] [Abstract][Full Text] [Related]
11. Expression levels of enzymes generating NO and CO in islets of murine and human diabetes.
Mohammed Al-Amily I; Lundquist I; Salehi A
Biochem Biophys Res Commun; 2019 Dec; 520(2):473-478. PubMed ID: 31607476
[TBL] [Abstract][Full Text] [Related]
12. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
13. The first total synthesis of cytopiloyne, an anti-diabetic, polyacetylenic glucoside.
Kumar CR; Tsai CH; Chao YS; Lee JC
Chemistry; 2011 Jul; 17(31):8696-703. PubMed ID: 21681841
[TBL] [Abstract][Full Text] [Related]
14. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
Gastaldelli A; Nauck MA; Balena R
Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
[TBL] [Abstract][Full Text] [Related]
15. Data on the effect of Cytopiloyne against
Chung CY; Yang WC; Liang CL; Liu HY; Lai SK; Chang CL
Data Brief; 2016 Jun; 7():995-998. PubMed ID: 27761492
[TBL] [Abstract][Full Text] [Related]
16. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
[TBL] [Abstract][Full Text] [Related]
17. The Potential Role of Zinc Oxide Nanoparticles in MicroRNAs Dysregulation in STZ-Induced Type 2 Diabetes in Rats.
Othman MS; Hafez MM; Abdel Moneim AE
Biol Trace Elem Res; 2020 Oct; 197(2):606-618. PubMed ID: 31845207
[TBL] [Abstract][Full Text] [Related]
18. Effects and molecular mechanisms of the antidiabetic fraction of Acorus calamus L. on GLP-1 expression and secretion in vivo and in vitro.
Liu YX; Si MM; Lu W; Zhang LX; Zhou CX; Deng SL; Wu HS
J Ethnopharmacol; 2015 May; 166():168-75. PubMed ID: 25792018
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of acorn (Quercus liaotungensis Koidz) on streptozotocin-damaged MIN6 cells and type 2 diabetic rats via p38 MAPK/Nrf2/HO-1 pathway.
Xu J; Fu C; Li T; Xia X; Zhang H; Wang X; Zhao Y
J Ethnopharmacol; 2021 Feb; 266():113444. PubMed ID: 33027641
[TBL] [Abstract][Full Text] [Related]
20. Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production.
Katakam AK; Chipitsyna G; Gong Q; Vancha AR; Gabbeta J; Arafat HA
J Endocrinol; 2005 Nov; 187(2):237-47. PubMed ID: 16293771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
